LINC02209: A Potential Drug Target Or Biomarker (G286135)

Target Name: LINC02209

NCBI ID: G286135

LINC02209

Other Name(s): FAM183CP | Long intergenic non-protein coding RNA 2209 | long intergenic non-protein coding RNA 2209

LINC02209: A Potential Drug Target Or Biomarker

LINC02209 (FAM183CP) is a protein that is expressed in various tissues and organs, including the brain, heart, and kidneys. It is a member of the FAM183 family of proteins, which are known for their role in intracellular signaling. LINC02209 has been shown to play a role in a variety of physiological processes, including cell survival, metabolism, and inflammation. As a result, it has potential as a drug target or biomarker.

The FAM183 family of proteins is characterized by the presence of a conserved domain that includes a leucine-rich repeat (LRR) and a carboxylic acid residue (CAR). This domain is present in multiple proteins, including LINC02209, and is thought to play a role in protein-protein interactions and intracellular signaling.

One of the unique features of LINC02209 is its ability to form a protein-protein interaction complex with other proteins. This interaction is thought to play a role in the regulation of various cellular processes, including cell survival, metabolism, and inflammation. For example, LINC02209 has been shown to interact with the protein p53, which is a well-known regulator of DNA damage repair and cell survival.

In addition to its role in intracellular signaling, LINC02209 has also been shown to play a role in the regulation of cellular processes outside of the cell. For example, it has been shown to play a role in the regulation of inflammation, as well as cell. migration and the assembly of tissues.

Given its potential role in a variety of cellular processes, LINC02209 has attracted the interest of researchers as a potential drug target or biomarker. Studies have shown that LINC02209 can be targeted by small molecules, including inhibitors of protein-protein interactions and inhibitors of intracellular signaling pathways. In addition, LINC02209 has been shown to be expressed in a variety of tissues and organs, including the brain, heart, and kidneys, which makes it a potential biomarker for a variety of diseases.

In conclusion, LINC02209 is a protein that has potential as a drug target or biomarker due to its role in intracellular signaling and its ability to form protein-protein interaction complexes. Further research is needed to fully understand the mechanisms of LINC02209's role in cellular processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2209

The "LINC02209 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02209 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets